SkinBioTherapeutics

SkinBioTherapeutics' platform applies the findings of research on the activity of probiotic lysates to the skin. The company has demonstrated that the SkinBiotix® platform can enhance the barrier effect of skin models, improve repair effects, and reduce bacterial load. SkinBioTherapeutics targets three specific areas of skin care: cosmetics, infection control, and eczema. In each of these areas, SkinBioTherapeutics plans to illustrate its technology through human studies. The most advanced program focuses on the application of the SkinBiotix® platform in managing sensitive skin within the cosmetics industry. The commercial strategy is to collaborate and license its programs at the proof-of-concept stage.